Navigation Links
Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
Date:1/12/2009

osis pathway, and three randomized chemotherapy combination trials are currently underway to evaluate its potential in the treatment of advanced multiple myeloma, non-small cell lung cancer, and hepatocellular cancer.

In May 2008, HGS initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced solid tumors. Results of this study will also help identify the recommended dose for Phase 2 trials. The IAP inhibitors are a novel class of compounds that block the activity of IAP (inhibitor of apoptosis) proteins, thus allowing apoptosis to proceed and causing the cancer cells to die. When IAP proteins are over-expressed in cancer cells, they can help cancer cells resist apoptosis and resume growth and proliferation.

FINANCIAL GUIDANCE

During his presentation to the JPMorgan Healthcare Conference, Mr. Watkins will present the following guidance regarding the financial results expected by HGS for the full years 2008 and 2009:

  • HGS expects 2009 net cash burn of less than $25 million, compared with approximately $245 million in 2008.
  • Revenue is expected to increase to $250 million or higher in 2009, from $48 million in 2008.
    • This includes at least $150 million from sale of 20,000 doses of ABthrax.
  • HGS expects cash and investments at year-end 2009 to total approximately $340 million, compared with approximately $365 million at the end of 2008.

PRESENTATION TO BE WEBCAST

Mr. Watkins' presentation to the 27th Annual JPMorgan Healthcare Conference will be webcast and may be accessed at www.hgsi.com. The presentation is scheduled to begin on January 14, 2009 at 7:30 AM Pacific or 10:30 AM Eastern
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... -- Fair Rate Funding, a leader in TV mesh lawsuit ... Delaware found Thursday that Boston Scientific,s Pinnacle ... prolapse (POP) and Stress Urinary Incontinence (SUI) in women, ... design flaws from the plaintiff, Deborah Barba . ... Transvaginal mesh, also known as TV mesh or ...
(Date:5/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/p37spr/north_america ) ... Open System MRI Market - Growth, Trends And Forecasts ... The key players in the industry are GE ... and Toshiba Medical Systems MRI ... because of its higher sensitivity and use of non-ionizing ...
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hgs483/cardiovascular ) ... report "Cardiovascular Drug Delivery - Technologies, Markets ... Drug delivery to the cardiovascular system is different ... anatomy and physiology of the vascular system; it ... the body. Drugs can be introduced into the ...
Breaking Medicine Technology:TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3
... Study -NAPA, Calif., March 13 ... the University of Maryland School of Medicine , was ... condition afflicting over 14 million Americans. Dr. Vinocur addressed ... the Department of Dermatology, University of California, Irvine , ...
... is one of a few institutions in the world ... Aurora St. Luke,s Medical Center is one ... a new skin cancer research study that trains the ... )The Young Tumor-Infiltrating Lymphocyte (Y-TIL) trial is a phase ...
Cached Medicine Technology:WBAL Radio Segment With Dr. Leigh Vinocur Addresses Hope for the Rosacea Sufferer 2New Hope to Beat Cancer 2
(Date:5/29/2015)... Jan Wooden Howse lost her husband and ... all else: God does no wrong. , It’s fitting, then, ... passing is titled “God Does No Wrong.” It focuses on ... personal tragedy. , “My story has a positive message ... into something productive, something healing,” Howse said. , “God Does ...
(Date:5/29/2015)... The Healthcare Delivery Institute at HORNE ... Training Program (ATP) in Healthcare Delivery Improvement. The ... health care organization ranging from clinicians to CFOs, ... quality improvement in the health care environment. The ... internationally recognized Advanced Training Program at Intermountain Healthcare. ...
(Date:5/29/2015)... Clearwater, FL (PRWEB) May 29, 2015 ... City, Utah, recently partnered with Stratus ... services, which will facilitate better communication and ... proficiency (LEP) and hearing loss. Stratus’ video ... Healthcare’s in-house translators, enabling staff to quickly ...
(Date:5/29/2015)... 2015 Mediaplanet has joined forces with ... on the importance of proper sun protection. The print ... with a circulation of approximately 250,000 copies and an ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ...
(Date:5/29/2015)... 2015 OncLive proudly announces the 2015 ... pioneers recognized by a panel of eminent oncologists for ... treatment. Honorees will be introduced and celebrated TONIGHT at ... held 8:30-11:00 p.m. CDT at The Chicago Illuminating Company, ... being recognized for groundbreaking accomplishments, in fields including translational ...
Breaking Medicine News(10 mins):Health News:Turning grief from a child’s passing into virtue 2Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4
... Sinai School of Medicine have found high levels of ... infants. Excessive food AGEs, through both maternal blood transmission ... for diseases such as diabetes from a very young ... that cutting back on processed, grilled, and fried foods, ...
... the Asthma and Allergy Foundation of America, asthma is the ... in the United States. It is the leading cause of ... accounting for an annual loss of more than 14 million ... now investigating the impact of risky family environments on asthma ...
... Gardner HealthDay Reporter , WEDNESDAY, Oct. 5 ... or antioxidants don,t help patients with severe lung problems ... According to the researchers, supplements may actually harm ... were on ventilators for more days, stayed in the ...
... (HealthDay News) -- Smokers have heart attacks earlier in life ... to suffer complications after a heart attack, according to a ... to the University of Michigan Medical Center from 1999 through ... the patients were current smokers. Male smokers were nine ...
... October 5, 2011 The Merck Childhood Asthma ... million in funding to implement the Community Healthcare ... partnership in five non-profit, Federally Qualified Health Centers. ... designed to demonstrate how asthma management tools proven ...
... Researchers Develop a New Tool That Helps Identify Prostate ... MIAMA BEACH, FL (October 4, 2011)After a prostate cancer ... amount of prostate-specific antigen, or PSA, in his blood. ... first detectable sign of the cancer,s return to the ...
Cached Medicine News:Health News:New study shows inflammatory food toxins found in high levels in infants 2Health News:New study shows inflammatory food toxins found in high levels in infants 3Health News:Wayne State University to study effects of risky family environments on childhood asthma 2Health News:Omega-3 Supplements Don't Help, May Hurt ICU Patients 2Health News:Omega-3 Supplements Don't Help, May Hurt ICU Patients 3Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 2Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 3Health News:New tool helps identify prostate cancer patients with highest risk of death 2
Sterile squares of smooth foil for repair of the floor of the orbit and other plastic surgery. Available in large size....
Clear Base Stand Magnifiers are ideal for any visual task that requires high magnification....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
Medicine Products: